Chinese biopharma Everest Medicines has won approval from China's National Medical Products Administration (NMPA) for Nefecon (budesonide) for the treatment of 24 November 2023
Life science investor Syncona has announced that its newly-established portfolio company has entered into an agreement to buy the remaining stake in Freeline Th 22 November 2023
Autifony Therapeutics, an independent biotech company formed in 2011 as a spin-out from GSK, has announced a collaboration with Ireland-headquartered Jazz Pharm 14 November 2023
Belgium’s largest pharma company, UCB, has announced new long-term data from the Bimzelx (bimekizumab) Phase IIb study BE AGILE and its open label extension (OL 10 November 2023
The National Institute for Health and Care Excellence (NICE) has recommended Lamzede (velmanase alfa) in its final evaluation document as an option for treating 9 November 2023
Israeli generics giant Teva Pharmaceutical Industries (TLV: TEVA) has reported its latest quarterly financial results against a backdrop of war in its home regi 8 November 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.